Arts and Sciences faculty featured on Academic Minute

Five faculty from the College of Arts and Sciences will be featured on a “Cornell week” on The Academic Minute radio program from May 1-5.

Around Cornell

Incubator to support projects for work and social change

The Yang-Tan WorkABILITY Incubator, recently launched through the ILR School’s Center for Applied Research on Work, will support innovative applied research projects and collaborations.

Racial equity messaging must be more inclusive

In a review of more than three decades’ worth of studies a Cornell-led research group found that more research on messaging that includes the voices of historically marginalized people is necessary in the push toward equity.

New research sheds light on how circadian rhythms work

New research from a multidisciplinary team helps to illuminate the mechanisms behind circadian rhythms, offering new hope for dealing with jet lag, insomnia and other sleep disorders.

Interfering with antiviral pathway may deter Alzheimer’s

Targeting part of a key antiviral pathway may one day offer a new therapeutic approach to deterring or delaying cognitive decline, according to preclinical research led by Weill Cornell Medicine scientists.

Knitted robotic textile promising for hand edema patients

Working with physicians at Weill Cornell Medicine and therapists at the Cayuga Medical Center, Cornell Hybrid Body Lab researchers have devised a knitted wearable technology that can ease discomfort caused by hand edema.

Law team opposes South Carolina’s electric chair, firing squad

Faculty, students and alumni affiliated with Cornell Law School's Capital Punishment Clinic are leading a legal fight to prevent South Carolina from executing condemned prisoners by methods they argue are cruel and unusual.

Circumstances influence happiness as much as personality

Happiness can’t be bought, but nor does it depend mostly on one’s mindset, as many happiness surveys would suggest, according to a recent study by Cornell psychology researchers.

Trial shows strong COVID protection in antibody combination

A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial.